Zeyad J El-Akawi1, Fatin K Al-Hindawi, Nabil A Bashir. 1. Department of Biochemistry and Molecular Biology, Jordan University of Science and Technology, School of Medicine, Irbid 22110, Jordan. zakawi@just.edu.jo
Abstract
BACKGROUND AND OBJECTIVES: Alpha-1 antitrypsin (alpha1-AT) is one of the most important extra-cellular serine protease inhibitors. Elevation of alpha1-AT serum levels have been observed in the course of a large number of malignant diseases. In this study, using Radial Immunodiffusion Method, we studied the serum levels of alpha1-AT in lung, prostate and breast cancer patients. RESULTS: Lung and prostate cancer patients have shown a significant elevation in alpha1-AT serum levels compared with those of healthy controls (P-value = 0,0001, 0,003 respectively). On the other hand, breast cancer patients did not show a significant change in these levels. Serum levels of alpha1-AT were 261.7 +/- 107.26, 222.7 +/- 87.30 and 183.8 +/- 45.05 mg/dl of lung, prostate and breast cancer patients, respectively, while those of healthy controls were 163.9 +/- 23.2 mg/dl in males and 186.13 +/- 39.81 mg/dl in females. CONCLUSION: These data demonstrated that alpha1-AT plasma levels might be an alarming factor to be considered in the diagnosis as well as in the follow up of cancer cases.
BACKGROUND AND OBJECTIVES:Alpha-1 antitrypsin (alpha1-AT) is one of the most important extra-cellular serine protease inhibitors. Elevation of alpha1-AT serum levels have been observed in the course of a large number of malignant diseases. In this study, using Radial Immunodiffusion Method, we studied the serum levels of alpha1-AT in lung, prostate and breast cancerpatients. RESULTS: Lung and prostate cancerpatients have shown a significant elevation in alpha1-AT serum levels compared with those of healthy controls (P-value = 0,0001, 0,003 respectively). On the other hand, breast cancerpatients did not show a significant change in these levels. Serum levels of alpha1-AT were 261.7 +/- 107.26, 222.7 +/- 87.30 and 183.8 +/- 45.05 mg/dl of lung, prostate and breast cancerpatients, respectively, while those of healthy controls were 163.9 +/- 23.2 mg/dl in males and 186.13 +/- 39.81 mg/dl in females. CONCLUSION: These data demonstrated that alpha1-AT plasma levels might be an alarming factor to be considered in the diagnosis as well as in the follow up of cancer cases.
Authors: R Shakya; G A Tarulli; L Sheng; N A Lokman; C Ricciardelli; K I Pishas; C I Selinger; M R J Kohonen-Corish; W A Cooper; A G Turner; P M Neilsen; D F Callen Journal: Oncogene Date: 2017-04-03 Impact factor: 9.867
Authors: Jessica C Amlin-Van Schaick; Sungjin Kim; Christina DiFabio; Min-Hyung Lee; Karl W Broman; Karlyne M Reilly Journal: Neuro Oncol Date: 2012-01-10 Impact factor: 12.300
Authors: Chae Hwa Kwon; Hye Ji Park; Jin Hwa Choi; Ja Rang Lee; Hye Kyung Kim; Hong-Jae Jo; Hyun Sung Kim; Nahmgun Oh; Geun Am Song; Do Youn Park Journal: Oncotarget Date: 2015-08-21
Authors: Marcio de Souza Cavalcante; José Camilo Torres-Romero; Marina Duarte Pinto Lobo; Frederico Bruno Mendes Batista Moreno; Leonardo Primo Bezerra; Diego Silva Lima; Jesamar Correia Matos; Renato de Azevedo Moreira; Ana Cristina de Oliveira Monteiro-Moreira Journal: Biomark Res Date: 2016-01-27